BEDOGNI, GISELLE R.; ARRUA, EVA CAROLINA; SEREMETA, KATIA P.; OKULIK, NORA B.; SALOMON, CLAUDIO J.

Elucidating the complexation of nifurtimox with cyclodextrins

JOURNAL OF MOLECULAR LIQUIDS; Lugar: Amsterdam; Año: 2023

ARRUA, EVA C.; HARTWIG, OLGA; LORETZ, BRIGITTA; MURGIA, XABIER; HO, DUY-KHIET; BASTIAT, GUILLAUME; LEHR, CLAUS-MICHAEL; SALOMÓN, CLAUDIO J.

Formulation of benznidazole-lipid nanocapsules: Drug release, permeability, biocompatibility, and stability studies

INTERNATIONAL JOURNAL OF PHARMACEUTICS; Año: 2023

RIVERO BERTI, IGNACIO; RODENAK-KLADNIEW, BORIS E.; KATZ, SERGIO F.; ARRUA, EVA CAROLINA; ALVAREZ, VERA A.; DURAN, NELSON; CASTRO, GUILLERMO R.

Enzymatic Active Release of Violacein Present in Nanostructured Lipid Carrier by Lipase Encapsulated in 3D-Bioprinted Chitosan-Hydroxypropyl Methylcellulose Matrix With Anticancer Activity

Frontiers in Chemistry; Año: 2022 vol. 10

ARRUA, EVA C.; HARTWIG, OLGA; LORETZ, BRIGITTA; GOICOECHEA, HÉCTOR; MURGIA, XABIER; LEHR, CLAUS-MICHAEL; SALOMON, CLAUDIO J.

Improving the oral delivery of benznidazole nanoparticles by optimizing the formulation parameters through a design of experiment and optimization strategy

COLLOIDS AND SURFACES B-BIOINTERFACES; Año: 2022 vol. 217

ARRUA, EVA C.; SANCHEZ, SOFÍA V.; TRINCADO, VALERIA; HIDALGO, ANTONIO; QUEST, ANDREW F.G.; MORALES, JAVIER O.

Experimental design and optimization of a novel dual-release drug delivery system with therapeutic potential against infection with Helicobacter pylori

COLLOIDS AND SURFACES B-BIOINTERFACES; Año: 2022 vol. 213

ARRUA, EVA C.; HARTWIG, OLGA; HO, DUY-KHIET; LORETZ, BRIGITTA; MURGIA, XABIER; SALOMON, CLAUDIO J.; LEHR, CLAUS-MICHAEL

Surfactant-Free Glibenclamide Nanoparticles: Formulation, Characterization and Evaluation of Interactions with Biological Barriers

PHARMACEUTICAL RESEARCH; Año: 2021

RIAL, M S; ARRÚA, E C; NATALE, M A; BUA, J; ESTEVA, M I; PRADO, N G; LAUCELLA, S A; SALOMON, C J; FICHERA, L E

Efficacy of continuous versus intermittent administration of nanoformulated benznidazole during the chronic phase of Trypanosoma cruzi Nicaragua infection in mice

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY; Año: 2020 vol. 75 p. 1906 - 1916

SEREMETA, KATIA P.; ARRÚA, EVA C.; OKULIK, NORA B.; SALOMON, CLAUDIO J.

Development and characterization of benznidazole nano- and microparticles: A new tool for pediatric treatment of Chagas disease?

COLLOIDS AND SURFACES B-BIOINTERFACES; Lugar: Amsterdam; Año: 2019

ARRÚA, EVA C.; SEREMETA, KATIA P.; BEDOGNI, GISELLE R.; OKULIK, NORA B.; SALOMON, CLAUDIO J.

Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of chagas disease: A review

ACTA TROPICA; Año: 2019 vol. 198

SILVA, LUCIANA DAMACENA; LIMA, NAYANA FERREIRA; ARRUA, EVA CAROLINA; SALOMON, CLAUDIO JAVIER; VINAUD, MARINA CLARE

In vivo treatment of experimental neurocysticercosis with praziquantel nanosuspensions—a metabolic approach

Drug Delivery and Translational Research; Año: 2018

RIAL, MARCELA S.; SCALISE, MARÍA L.; ARRÚA, EVA C.; ESTEVA, MÓNICA I.; SALOMON, CLAUDIO J.; FICHERA, LAURA E.

Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease

PLOS NEGLECTED TROPICAL DISEASES; Año: 2017 vol. 11

LUCIANA DAMACENA SILVA; EVA CAROLINA ARRUA; DAYANNE AMARAL PEREIRA; CAROLINA MIGUEL FRAGA; TATIANE LUIZA DA COSTA; ANDREW HEMPHILL; CLAUDIO J. SALOMON; MARINA CLARE VINAUD

Elucidating the influence of praziquantel nanosuspensions on the in vivo metabolism of Taenia crassiceps cysticerci.

ACTA TROPICA; Lugar: Amsterdam; Año: 2016 vol. 161 p. 100 - 105

MARIA L. SCALISE*; EVA CAROLINA ARRUA*; MARCELA S. RIAL; MÓNICA I. ESTEVA; CLAUDIO J. SALOMON; LAURA E. FICHERA; *PRIMERA AUTORÍA COMPARTIDA

Promising Efficacy of Benznidazole Nanoparticles in Acute Trypanosoma cruzi Murine Model: In-Vitro and In-Vivo Studies.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE; Lugar: Stanford; Año: 2016

EVA CAROLINA ARRUA; M.JOÃO G. FERREIRA; CLAUDIO J. SALOMON; TERESA G. NUNES

Elucidating the guest-host interactions and complex formation of praziquantel and cyclodextrin derivatives by (13)C and (15)N solid-state NMR spectroscopy.

INTERNATIONAL JOURNAL OF PHARMACEUTICS; Lugar: Amsterdam; Año: 2015 vol. 496 p. 812 - 821